Pimobendan is a heart medication used to treat dogs with congestive heart failure (CHF) usually caused by dilated cardiomyopathy or valvular insufficiency
A Anant Labs fabrica e fornece impurezas de Pimobendan de alta qualidade para o mercado global. Nossas impurezas EP de Pimobendan são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
rac Pimobendanpimobendan74150-27-9pimobendaneAcardidl-PimobendanVetmedinPimobendanumUD-CG-115BSRacemic pimobendanUD-CG-115UDCG-11534AP3BBP9TDTXSID8048280CHEBI:32003FORTEKOR PLUS COMPONENT PIMOBENDAN3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-4,5-dihydropyridazin-3(2H)-oneUD-CG115Pimobendan,USPVetmedin SolutionPimobendan EP56-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-4,5-dihydropyridazin-3(2H)-oneVetmedin-CA1RefChem:55860SolutitionKits PimobendanDTXCID90282554,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazole-5-yl)-5-methyl-3(2H)-pyridazinoned-PimobendanPimobendan, (-)-(-)-Pimobendanl-Pimobendan(+)-Pimobendan118428-37-86-(2-(4-METHOXYPHENYL)-1H-BENZO[D]IMIDAZOL-5-YL)-5-METHYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONEPimobendan, (+)-Pimobendan (Vetmedin)MFCD007616483-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one118428-38-9BRN 4207330CHEMBL24646613JXV89SU9HTU209Z0N3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (+)-3(2H)-Pyridazinone, 4,5-dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-, (-)-Racemic pinobendanUD-CG 115UD-CG 115 BSPimobendan [INN-Spanish]Pimobendane [INN-French]Pimobendanum [INN-Latin](+)-UD-CG 115BS(-)-UD-CG 115BSNCGC00274063-01UNII-34AP3BBP9TUNII-613JXV89SUUNII-9HTU209Z0NPimobendamPimobendan [USAN:INN:BAN]Pimobendan?4,5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methyl-3(2H)-pyridazinonePimobendan CRSGLBJJMFZWDBELO-UHFFFAOYSA-NAcardi (TN)Pimobendan (Standard)PIMOBENDAN [MI]PIMOBENDAN [INN]PIMOBENDAN [JAN]PIMOBENDAN [USAN]PIMOBENDAN [MART.](+)-4,5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone(-)-4,5-Dihydro-6-(2-(4-methoxyphenyl)-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinone6-(2-(4-Methoxyphenyl)-4,5-dihydro-1H-benzimidazol-5-yl)-5-methyl-3(2H)-pyridazinonePIMOBENDAN [USP-RS]PIMOBENDAN [WHO-DD]SCHEMBL27623MLS006010188Pimobendan (JAN/USAN/INN)orb1307669orb1695666SCHEMBL1649737PIMOBENDAN [GREEN BOOK]PIMOBENDAN [EP IMPURITY]Pimobendan, >=98% (HPLC)SCHEMBL29386190HY-B0204RGLXC-07557HMS3655I03HMS3884C21HMS5079O14KUC109647NPIMOBENDAN [USP MONOGRAPH]HY-B0204MSK14881AC-689BDBM50282617s1550AKOS015851937AKOS015967705CCG-267853DB11450EBC-130025FP38260KS-1280KSC-210-009PIMOBENDAN [EMA EPAR VETERINARY]Pimobendan 100 |Ig/mL in AcetonitrileNCGC00274063-04NCGC00274063-05118428-36-7Pimobendan 100 microg/mL in AcetonitrileSMR002530068SY122254DB-219709P2779Pimobendan for veterinary use [ep monograph]SW219717-1D01133SBI-0654181.0001T34067AB01274800-01AB01274800_02EN300-27067685F863694Q414351BRD-A84575140-001-02-4Pimobendan, United States Pharmacopeia (USP) Reference Standard4,5-dihydro-6-[2-(4-methoxy-phenyl)-1h-benzimidazol-5-yl]-5-methyl-3 (2h)-pyridazinone4,5-Dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-5-methyl-3(2H)-pyridazinone6-[2-(4-Methoxyphenyl)-3H-benzimidazol-5-yl]-5-methyl-4,5-dihydro-2H-pyridazin-3-onePimobendan for system suitability, European Pharmacopoeia (EP) Reference Standard(+/-)-4,5-DIHYDRO-6-(2-(P-METHOXYPHENYL)-5-BENZIMIDAZOLYL)-5-METHYL-3(2H)-PYRIDAZINONE(5RS)-6-[2-(4-Methoxyphenyl)-1H-benzimidazol-5-yl]-5- methyl-4,5-dihydropyridazin-3(2H)-one3(2H)-PYRIDAZINONE, 4,5-DIHYDRO-6-(2-(4-METHOXYPHENYL)-1H-BENZIMIDAZOL-5-YL)-5-METHYL-, (+/-)-3(2H)-PYRIDAZINONE, 4,5-DIHYDRO-6-(2-(4-METHOXYPHENYL)-1H-BENZIMIDAZOL-6-YL)-5-METHYL-6-[2-(4-Methoxyphenyl)-1H-1,3-benzimidazol-6-yl]-5-methyl-4,5-dihydropyridazin-3(2H)-one6-[2-(4-methoxyphenyl)-1H-1,3-benzodiazol-6-yl]-5-methyl-2,3,4,5-tetrahydropyridazin-3-one
